Home
About MMJ
Patients
Health Care Professionals
Investors
Investor Information
News
Contact
MMJ BioPharma Labs Receives DEA Schedule 1 Registration
Home
News
mmj
MMJ BioPharma Labs Receives DEA Schedule 1 Registration
MMJ BioPharma Labs – Stem Solutions Completes Schedule 1 Analytical Lab
May 13, 2022
MMJ Files Writ Of Mandamus Against DEA
May 13, 2022
May 13, 2022
https://www.yahoo.com/now/mmj-biopharma-labs-moves-forward-054000630.html
Related posts
May 14, 2022
WHY MMJ CANNNABIS RESEARCH AND CLINICAL TRIALS ARE NEEDED
Read more
May 13, 2022
DEA Delays Marijuana Researcher
Read more
May 13, 2022
MMJ BioPharma Cultivation Producing Marijuana to DEA Regulations
Read more
